Feb.01.2021
Corporate

Notice concerning the Establishment of Ono Pharma Healthcare Co., Ltd.

 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara; “ONO”) announced today that Ono has resolved to establish Ono Pharma Healthcare Co., Ltd., whose main business is health foods and foods with function claims in the healthcare field.

1. Purpose for establishment:

 We have decided to work on a solution service business in the healthcare field, in order to contribute to solving various social issues associated with the development of a super-aging society. We will contribute to an extension of healthy life expectancy and a sustainable society, by maximizing the assets that we have cultivated through the research and development of ethical drugs so far and developing the health food and foods with function claims business in the healthcare field.

2. Outline of the subsidiary to be established:

Name Ono Pharma Healthcare Co., Ltd.
Location 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka
Established February 5, 2021 (planned)
Representative Yasunari Noda, President
Staff 4 persons (planned)
Business Health food and foods with function claims business in the healthcare field
Capital JPY 10 million
Relationship A wholly-owned subsidiary of ONO

3. Future outlook

 An impact of this matter on the Company's business results for the current fiscal year would be marginal. Should there be any events to be disclosed in the future, we will announce them in a timely manner.